FDG PET in the management of lymphoma: a clinical perspective.
Hoskin
P J
PJ
D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000000981:diagnostic imaging* / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging* / Q000628:therapy; D009367:Neoplasm Staging / Q000295:instrumentation / Q000379:methods*; D011237:Predictive Value of Tests; D011859:Radiography; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D014055:Tomography, Emission-Computed / Q000379:methods*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18